Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News AVITA Medical Inc RCEL

Healthcare Biotechnology
AVITA Medical, Inc. is a commercial-stage regenerative medicine company. The Company is a provider of regenerative medicine addressing unmet medical needs in burn injuries, full-thickness skin defects, and in skin repigmentation, such as vitiligo. Its RECELL platform a single use, stand-alone, battery operated, autologous cell harvesting device containing enzymatic and buffer solutions, sterile... see more

Recent & Breaking News (NDAQ:RCEL)

AVITA Medical to Host Investor Webinar Briefing

GlobeNewswire 2 days ago

AVITA Medical Reports First Quarter Financial Results

GlobeNewswire 5 days ago

AVITA Medical to Announce First Quarter 2024 Financial Results

GlobeNewswire April 15, 2024

AVITA Medical Updates Expected First Quarter 2024 Revenue

GlobeNewswire April 10, 2024

AVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA Supplement

GlobeNewswire February 29, 2024

AVITA Medical to Present at TD Cowen 44th Annual Health Care Conference

GlobeNewswire February 29, 2024

AVITA Medical to Host Investor Webinar Briefing

GlobeNewswire February 23, 2024

AVITA Medical Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance

GlobeNewswire February 22, 2024

AVITA Medical to Announce Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire February 1, 2024

AVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific

GlobeNewswire January 10, 2024

AVITA Medical Announces Preliminary 2023 Financial Highlights, Provides 2024 Financial Guidance and Business Update

GlobeNewswire January 10, 2024

AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 4, 2024

AVITA Medical to Host Investor Webinar Briefing

GlobeNewswire December 4, 2023

AVITA Medical to Present at the Piper Sandler 35th Annual Healthcare Conference

GlobeNewswire November 21, 2023

AVITA Medical Updates Full Year 2023 Guidance

GlobeNewswire November 20, 2023

AVITA Medical Reports Third Quarter Financial Results with 51% Revenue Growth over the Same Period the Prior Year

GlobeNewswire November 9, 2023

AVITA Medical Announces Distribution Partnership with PolyMedics Innovations to Expand to Europe

GlobeNewswire November 9, 2023

AVITA Medical to Announce Third Quarter 2023 Financial Results

GlobeNewswire October 19, 2023

AVITA Medical Announces Preliminary Third Quarter 2023 Financial Highlights and Secures up to $90 million of Non-Dilutive Debt Financing with OrbiMed to Support Growth Initiatives

GlobeNewswire October 18, 2023

AVITA Medical Receives Best Product Award at the American Association for the Surgery of Trauma

GlobeNewswire September 25, 2023